The analysis of COVID-19 in saliva, gastric fluid and intestinal fluid on gastrointestinal endoscopy

The analysis of COVID-19 in saliva, gastric fluid and intestinal fluid on gastrointestinal endoscopy - The analysis of COVID-19 on gastrointestinal endoscopy

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000040587

Enrollment

500

Registered

2020-06-01

Start date

2020-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Participants who receive endoscopy

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The all patients who receive endoscopy

Exclusion criteria

Exclusion criteria: COVID-19 suspected from questionnaire and medical interview Not willing to participate this study Emergency endoscopy

Design outcomes

Primary

Measure	Time frame
The positive rate of COVID-19 in saliva, gastric fluid and intestinal fluid on gastrointestinal endoscopy	—

Secondary

Measure	Time frame
The value of COVID-19 antibody The purpose of endoscopy The patients background	—

Countries

Japan

Contacts

Public ContactTakuma HIGURASHI

Yokohama City University Department of gastroenterology and hepatology

takuma_h@yokohama-cu.ac.jp045-787-2800

Outcome results